Search results for: Precision Medicine
Filter search results
International Drug Pricing Transparency
20 July 2020, 11:00pm
…the WHO Fair Pricing Forum, MSF claimed that “secret medicine prices cost lives”, and the WHO resolution urged countries to collect and share net price information. More recently, during the…
Mireia Jofre-Bonet
8 January 2019
…London School of Hygiene & Tropical Medicine, the London School of Economics and Political Science, and the Department of Public Health of Yale University. She actively contributes to policy discussions…
Join Us in Our 50th Anniversary Celebration!
7 February 2012
…1962, at the time when international emphasis on prescription medicine efficacy and safety was just beginning, OHE has made significant contributions in several fields since that time. A range of…
Can lessons from valuing health be useful in valuing development aid?
25 March 2012
…doesn’t, much as a randomised clinical trial does in medicine. Outcome measures could be used to compare changes in the whole population or in sectors over time, identifying when aid…
Join OHE for Its 50th Anniversary Annual Lecture with Sir Michael Rawlins
12 April 2012
…the “gold standard”, instead urging a more pragmatic approach. Sir Michael’s experience – as a clinician, chair of the Committee on Safety of Medicines, and chair of NICE — uniquely…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 May 2012
…practice and expected production cost, rather than assessments of value. The paper discusses how a value based pricing (VBP) framework for efficient use and pricing of medicines also might be…
Bold politics – what about the economics?: An overview of President Trump’s ‘Most Favoured Nation’ Executive Order
2 June 2025
…in purchasing medicines, in contrast to the greater reliance on the private market seen in the U.S.” How is this Executive Order different to the previous one in 2020? The…
Around the World in HTAs: Kenya – Riding the Waves of Change
19 May 2025
…Subsequently, a HTA focal point within MoH was introduced to oversee and coordinate HTA institutionalisation activities (2020), the Medicines Affordability Pricing Advisory Committee (MAPAC) was tasked to promote access, availability,…
Breaking the European Deadlock: Part 2 – Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?
4 January 2024
…Transferable Exclusivity Vouchers and Incentives for Antimicrobial Development in the European Union. Journal of Law, Medicine & Ethics. 51(1):213-216. doi:10.1017/jme.2023.58 Wilsdon et al. (2022). A framework for assessing the potential net…